Musical hallucinations treated with acetylcholinesterase inhibitors

Frontiers in Psychiatry

Volumn 6, Issue APR, 2015, Pages

  Blom, Jan Dirk ^a,b   Coebergh, Jan Adriaan F ^c,d   Lauw, René ^a   Sommer, Iris E C ^e,f  

^a PARNASSIA PSYCHIATRIC INSTITUTE   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c ASHFORD AND ST PETER'S HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^d ST GEORGE S HOSPITAL   (United Kingdom)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Auditory Charles Bonnet syndrome; Cholinergic system; Deafferentiation; Donepezil; Hearing loss; Oliver Sacks' syndrome; Release hallucination; Rivastigmine

Indexed keywords

ACETYLSALICYLIC ACID; CHOLINESTERASE INHIBITOR; CLOPIDOGREL; MIRTAZAPINE; RIVASTIGMINE; VALPROIC ACID;

AGED; ARTICLE; AUDITORY HALLUCINATION; CASE REPORT; COMORBIDITY; DEPRESSION; DETERIORATION; DISTRESS SYNDROME; DIZZINESS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG MECHANISM; DRUG SUBSTITUTION; DRUG USE; ELECTROENCEPHALOGRAM; FEMALE; HEARING IMPAIRMENT; HUMAN; MENTAL FUNCTION; MUSIC; MUSICAL HALLUCINATION; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PSYCHIATRIC DIAGNOSIS;

EID: 84930669098     PISSN: None     EISSN: 16640640     Source Type: Journal    
DOI: 10.3389/fpsyt.2015.00046     Document Type: Article

References (33)

1. Berrios GE. Musical hallucinations. A historical and clinical study. Br J Psychiatry (1990) 156:188-94. doi:10.1192/bjp.156.2.188.
2. Sacks O. The power of music. Brain (2006) 129:2528-32. doi:10.1093/brain/awl234.
3. Cope TE, Baguley DM. Is musical hallucination an otological phenomenon? A review of the literature. Clin Otolaryngol (2009) 34:423-30. doi:10.1111/j.1749-4486.2009.02013.x.
4. Sacks O, Blom JD, Musical hallucinations. In: Blom JD, Sommer IEC, editors. Hallucinations. Research and Practice. New York, NY: Springer (2012). p. 133-42.
5. Teunisse RJ, Olde Rikkert MG. Prevalence of musical hallucinations in patients referred for audiometric testing. Am J Geriatr Psychiatry (2012) 20:1075-7. doi:10.1097/JGP.0b013e31823e31c4.
6. Shinosaki K, Yamamoto M, Ukai S, Kawaguchi S, Ogawa A, Ishii R, et al. Desynchronization in the right auditory cortex during musical hallucinations: a MEG study. Psychogeriatrics (2003) 3:88-92. doi:10.1046/j.1479-8301.2003.00009.x.
7. Kumar A, Sedley W, Barnes GR, Teki S, Friston KJ, Griffiths TD. A brain basis for musical hallucinations. Cortex (2014) 52:86-97. doi:10.1016/j.cortex.2013.12.002.
8. Baba A, Hamada H. Musical hallucinations in schizophrenia. Psychopathology (1999) 32:242-51. doi:10.1159/000029096.
9. Evers S, Ellger T. The clinical spectrum of musical hallucinations. J Neurol Sci (2004) 227:55-65. doi:10.1016/j.jns.2004.08.004.
10. Hermesh H, Konas S, Shiloh R, Dar R, Marom S, Weizman A, et al. Musical hallucinations: prevalence in psychotic and nonpsychotic outpatients. J Clin Psychiatry (2004) 65:191-7. doi:10.4088/JCP.v65n0208.
11. Evers S. Musical hallucinations. Curr Psychiatry Rep (2006) 8:205-10. doi:10.1007/s11920-006-0024-0.
12. Colon-Rivera HA, Oldham MA. The mind with a radio of its own: a case report and review of the literature on the treatment of musical hallucinations. Gen Hosp Psychiatry (2014) 36:220-4. doi:10.1016/j.genhosppsych.2013.10.021.
13. Allen JR. Salicylate-induced musical perceptions. N Engl J Med (1985) 313:642-3. doi:10.1056/NEJM198509053131020.
14. Ukai S, Yamamoto M, Tanaka M, Shinosaki K, Takeda M. Donezepil in the treatment of musical hallucinations. Psychiatry Clin Neurosci (2007) 61:190-2. doi:10.1111/j.1440-1819.2007.01636.x.
15. Strauss M, Gertz HJ. Treatment of musical hallucinations with acetylcholinesterase inhibitors. J Neurol Neurosurg Psychiatry (2009) 80:1298-9. doi:10.1136/jnnp.2008.160978.
16. Zilles D, Zerr I, Wedekind D. Successful treatment of musical hallucinations with the acetylcholinesterase inhibitor donezepil. J Clin Psychopharmacol (2012) 32:422-4. doi:10.1097/JCP.0b013e318253a086.
17. Blom JD, Sommer IEC, Koops S, Sacks O. Prosopometamorphopsia and facial hallucinations. Lancet (2014) 384:1998. doi:10.1016/S0140-6736(14)61690-1.
18. Bauer M, Kluge C, Bach D, Bradbury D, Heinze HJ, Dolan RJ, et al. Cholinergic enhancement of visual attention and neural oscillations in the human brain. Curr Biol (2012) 22:397-402. doi:10.1016/j.cub.2012.01.022.
19. Figiel G, Sadowsky C. A systematic review of the effectiveness of rivastigmine for the treatment of behavioral disturbances in dementia and other neurological disorders. Curr Med Res Opin (2008) 24:157-66. doi:10.1185/030079908X260961 s.
20. Poewe W. What to do. When a Parkinson's disease patient starts to hallucinate. Pract Neurol (2008) 8:238-41. doi:10.1136/jnnp.2008.152579.
21. Zahodne LB, Fernandez HH. Pathophysiology and treatment of psychosis in Parkinson's disease. Drugs Aging (2008) 25:665-82. doi:10.2165/00002512-200825080-00004.
22. Ukai S, Yamamoto M, Tanaka M, Takeda M. Treatment of typical Charles Bonnet syndrome with donezepil. Int Clin Psychopharmacol (2004) 19:355-7. doi:10.1097/00004850-200411000-00008.
23. Leach ND, Nodal FR, Cordery PM, King AJ, Bajo VM. Cortical cholinergic input is required for normal auditory perception and experience-dependent plasticity in adult ferrets. J Neurosci (2013) 33:6659-71. doi:10.1523/JNEUROSCI.5039-12.2013.
24. Irimajiri R, Michalewski HJ, Golob EJ, Starr A. Cholinesterase inhibitors affect brain potentials in amnestic mild cognitive impairment. Brain Res (2007) 1145:108-16. doi:10.1016/j.brainres.2007.01.120.
25. Babiloni C, Del Percio C, Bordet R, Bourriez JL, Bentivoglio M, Payoux P, et al. Effects of acetylcholinesterase inhibitors and memantine on resting-state electroencephalographic rhythms in Alzheimer's disease patients. Clin Neurophysiol (2013) 124:837-50. doi:10.1016/j.clinph.2012.09.017.
26. Weinberger NM. Neuromusic research: some benefits of incorporating basic research on the neurobiology of auditory learning and memory. Front Syst Neurosci (2013) 7:128. doi:10.3389/fnsys.2013.00128.
27. Gordon AG. Tricyclic-induced musical hallucinations. Biol Psychiatry (1996) 40:309-10. doi:10.1016/0006-3223(96)00066-2.
28. Mori T, Ikeda M, Fukuhara R, Suqawara Y, Nakata S, Matsumoto N, et al. Regional cerebral blood flow change in a case of Alzheimer's disease with musical hallucinations. Eur Arch Psychiatry Clin Neurosci (2006) 256:236-9. doi:10.1007/s00406-005-0631-5.
29. Anand R, Gharabawi G, Enz A. Efficacy and safety results of the early phase studies with Exelon (ENA 713) in Alzheimer's disease: an overview. J Drug Dev Clin Pract (1996) 8:109-16.
30. Enz A, Amstutz R, Boddeke H. Brain selective inhibition of acetylcholinesterase: a novel approach to therapy for Alzheimer's disease. Prog Brain Res (1993) 98:431-8. doi:10.1016/S0079-6123(08)62429-2.
31. Warner N, Aziz V. Hymns and arias: musical hallucinations in older people in Wales. Int J Geriatr Psychiatry (2005) 20:658-60. doi:10.1002/gps.1338.
32. Diederen KMJ, Neggers SFW, Daalman K, Blom JD, Goekoop R, Kahn RS, et al. Deactivation of the parahippocampal gyrus preceding auditory hallucinations in schizophrenia. Am J Psychiatry (2010) 167:427-35. doi:10.1176/appi.ajp.2009.09040456.
33. Rossignol DA, Frye RE. The use of medications approved for Alzheimer's disease in autism spectrum disorder: a systematic review. Front Pediatr (2014) 2:87. doi:10.3389/fped.2014.00087.